CSR Biotech
PrivateLast Round
Series B
Sep 20, 2024
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CSR Biotech operates in Healthcare & Life Sciences and is based in Guangzhou. Its latest recorded funding round was a Series B round in September 2024.
CSR Biotech is a life-sciences instrumentation company that develops and manufactures super-resolution optical microscopy systems for advanced biological research.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Medical Imaging, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CSR Biotech Comparables
Compare CSR Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Naxi Tech | 92% | |
| Confocal NL | 87% | |
| ONI | 84% |
For institutional investors. Book with your work email.
CSR Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 20, 2024 | ||||
| Series A | Aug 22, 2023 | ||||
| Early Funding | Sep 8, 2022 | ||||
| Early Funding | Mar 22, 2022 |
For institutional investors. Book with your work email.
CSR Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Co-Win Ventures | Early Funding |
| Northern Light Venture Capital | Early Funding |
| CAS Star | Early Funding |
| Shenzhen Dachen Caizhi Venture Capital Management | Early Funding |
| Guangzhou Industrial Investment Holding Group | Series B |
| Lilly Asia Ventures | Series A |
| 启迪之星创投 | Early Funding |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 1396% MoM, from 54 to 808.
- Mar 4, 2026
Monthly visitors grew 53% MoM.
For institutional investors. Book with your work email.
CSR Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CSR Biotech's valuation, stock price, and market status.
Is CSR Biotech a public or private company?
CSR Biotech is a private company.
What is the current stock price of CSR Biotech?
CSR Biotech is a private company, so its shares have no public market price. Caplight tracks CSR Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CSR Biotech worth (valuation)?
Valuation information for CSR Biotech is not publicly available.
Can I buy CSR Biotech stock?
CSR Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CSR Biotech's last funding round?
CSR Biotech's most recent funding round was Series B on September 20, 2024.
Who are the main investors in CSR Biotech?
Key investors in CSR Biotech include Northern Light Venture Capital, Lilly Asia Ventures, Qiming Venture Partners.
Will CSR Biotech IPO soon?
No public IPO plans have been announced for CSR Biotech.
How can I track CSR Biotech secondary market activity?
Caplight tracks bids, offers, and trades in CSR Biotech's shares on secondary markets.